Pocong, John Wilson A.
HRN: 26-84-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
CEFUROXIME 1.5GM (VIAL)
03/18/2025
03/25/2025
IV
1.5g
Q8H
Lacerated Wound, Upper Lip
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes